Dana E DeJohn

Title: Dana E DeJohn: Innovator in Modified Tripeptides

Introduction

Dana E DeJohn is a notable inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of biochemistry, particularly in the development of modified tripeptides. Her work focuses on innovative solutions for treating cognitive disorders and other health issues.

Latest Patents

Dana E DeJohn holds a patent for "Modified tripeptides," which includes modified oxytocin-vasopressin di- or tri-peptides. This patent describes compounds wherein an amide group is replaced by various functional groups, such as --CH.sub.2 NH--, --CH.sub.2 O--, and others. The patent also outlines methods for their manufacture, pharmaceutical compositions, and treatment methods, especially for cognitive disorders, depression, morphine dependency, and parkinsonism through adjunctive therapy. She has 1 patent to her name.

Career Highlights

Dana has worked with Warner-Lambert Company, where she has been able to apply her expertise in biochemistry to develop innovative therapeutic solutions. Her career reflects a commitment to advancing medical science through her research and inventions.

Collaborations

Throughout her career, Dana has collaborated with esteemed colleagues, including Ernest D Nicolaides and Francis John Tinney. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Dana E DeJohn is a pioneering inventor whose work in modified tripeptides has the potential to impact the treatment of various cognitive disorders. Her contributions to the field of biochemistry are noteworthy and continue to inspire future innovations.